Journal
/
Cancer Research
/
Terapötik Hidrojel Araştırmaları içinblastoma Relaps Post-Rezeksiyon Modeli…
JoVE Journal
Cancer Research
Cancer Research
This content is Free Access.
Terapötik Hidrojel Araştırmaları için Glioblastoma Relaps Post-Rezeksiyon Modeli
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/65026-v
•
04:46 min
•
February 24th, 2023
Terapötik Hidrojel Araştırmaları için Glioblastoma Relaps Post-Rezeksiyon Modeli
February 24th, 2023
•
1Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, 2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University
* These authors contributed equally
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Mevcut protokol, in vivo olarak enjekte edilebilir, biyo-duyarlı bir hidrojelin terapötik etkisini araştırmak için mikroskopi kullanarak bir glioblastoma (GBM) relaps sonrası modeli oluşturur.